ClinicalTrials.gg
RecruitingNCT05751694Updated Feb 26, 2025

Effectiveness of Visceral Manual Therapy in Bruxist Patients

An interventional study of Visceral manual treatment and Respiratory listening in Bruxism, sponsored by University of Seville. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-26.

Sponsored by University of Seville · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Objective: check the effectiveness of visceral manual therapy on bruxist patients Design: Experimental, analytical, longitudinal, prospective, randomized, single-blind study with a blinded evaluator.

Subjects: 68 subjects over 18 years old, with bruxism (diagnoses by a dentist). Methods: Subjects will be randomized into 2 groups: an experimental group (EG) to which a visceral manual technique will be applied and a control group (CG) to which a placebo manual technique will be administered. Both groups will receive 2 interventions one week apart. The measurements will be made before and after the interventions, and a last measurement will be made one month after the last intervention. Therefore, the patient will visit the center 3 times.

02

Conditions studied

  • Bruxism

Browse trials for

Keywords

  • Bruxism
  • Musculoskeletal Manipulations
  • Physical Therapy Modalities
  • Autonomic Nervous System
03

In context

Bruxism

151 studies on the registry are indexed under Bruxism; 39 are open to participants now.

This study's planned enrollment of 68 is above the median of 39 across 94 interventional studies indexed under Bruxism.

Browse Bruxism studies →

Lead sponsor

University of Seville is the lead sponsor of 130 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects with bruxism diagnosed and referred by a dentist
  • Age: older than 18 years-old.

Exclusion criteria

Exclusion Criteria:

  • Recent craniofacial, mandibular or cervical trauma or fracture.
  • Temporomandibular joint surgery.
  • Acute pain due to other components of the masticatory system (caries, inflammation of the dental root).
  • Abdominal surgery.
  • Gastric ulcers.
  • Gastritis.
  • Previous or current gastric neoplasm.
  • Neurological or systemic diseases.
  • Pregnant, including the period of breastfeeding.
  • Patients receiving chemotherapy or radiotherapy.
  • Cognitive, psychosomatic or psychiatric illnesses that may affect the data obtained.
  • Basic systemic disease of rheumatic origin (for example, arthritis, osteoarthritis, gout and psoriasis).
  • Cerebrovascular and brain diseases.
  • Arrhythmia and other cardiac problems.
  • Implanted electronic devices.
  • Drug or alcohol abuse, analgesic or sedative therapy, and use of medications that affect the central nervous system (for example, antidepressants, anxiolytics, and anticonvulsants).
  • Patients who have previous experience with manual treatment of the diaphragm
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    Visceral manual treatment

    The objective of this technique is to reduce the tension of the tissues of the epigastric area.

    Procedure: Visceral manual treatment

  • Active comparator
    Respiratory listening

    It is a maneuver to evaluate the mobility of the ribs during respiration.

    Procedure: Respiratory listening

Interventions

  • ProcedureVisceral manual treatment

    The patient will be placed in a reclining sitting position and triple flexion of the lower limbs to keep the abdominal region relaxed. The therapist will be placed to the right of the patient at the height of the abdomen, with the hands placed in the epigastric area. He will make a skin fold that reduces tension in the area, so that the contact is focused on the visceral tissue of the area. The patient will be asked to take deep breaths, and during the exhalation, the therapist will perform a zigzag movement with vibration of the hands while pulling the tissue caudally. This procedure will be performed for 5 minutes.

  • ProcedureRespiratory listening

    The patient and the therapist will be placed in the same position as in the experimental group. The therapist will place his hands in contact with the lower rib cage, and the patient will be asked to take a deep breath. The therapist will not exert any pressure, nor place restrictions on the tissues or movements of the ribcage.

06

What researchers measure

Primary outcomes

  1. Pressure pain threshold (PPT) Baseline-1

    The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Baseline pre-intervention

  2. PPT Change-1

    The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "PTT Baseline-1" immediately post-intervention

  3. PPT Baseline-2

    The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Baseline pre-intervention at 7 days

  4. PPT Change-2

    The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "PTT Baseline-2" immediately post-intervention

  5. PPT Change-3

    The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "PTT Baseline-2" and "PTT Change-2" at 1 month

  6. Heart Rate Variability (HRV) Baseline-1

    Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

    Time frame: Baseline pre-intervention

  7. HRV Change-1

    Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

    Time frame: Change from "HRV baseline-1" inmediately post-intervention

  8. HRV Baseline-2

    Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

    Time frame: Baseline pre-intervention at 7 days

  9. HRV Change-2

    Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

    Time frame: Change from "HRV baseline-2" inmediately post-intervention

  10. HRV Change-3

    Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

    Time frame: Change from "HRV baseline-2" and "HRV change-2" at 1 month

  11. Myotonometry baseline-1

    The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Baseline pre-intervention

  12. Myotonometry change-1

    The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "myotonometry baseline-1" inmediately post-intervention

  13. Myotonometry baseline-2

    The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Baseline pre-intervention at 7 days

  14. Myotonometry change-2

    The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "myotonometry baseline-2" inmediately post-intervention

  15. Myotonometry change-3

    The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "myotonometry baseline-2" and "myotonometry change-2" at 1 month

Secondary outcomes

  1. Cervical Range of Motion (CROM) Baseline-1

    The evaluator will place the CROM-device® goniometer on the patient's head. It will ask you for movements of flexion, extension, right and left side flexion, and right and left rotation of the cervical spine. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Baseline pre-intervention

  2. Cervical Range of Motion (CROM) Change-1

    The evaluator will place the CROM-device® goniometer on the patient's head. It will ask you for movements of flexion, extension, right and left side flexion, and right and left rotation of the cervical spine. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "CROM Baseline-1" immediately post-intervention

  3. Cervical Range of Motion (CROM) Baseline-2

    The evaluator will place the CROM-device® goniometer on the patient's head. It will ask you for movements of flexion, extension, right and left side flexion, and right and left rotation of the cervical spine. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Baseline pre-intervention at 7 days

  4. Cervical Range of Motion (CROM) Change-2

    The evaluator will place the CROM-device® goniometer on the patient's head. It will ask you for movements of flexion, extension, right and left side flexion, and right and left rotation of the cervical spine. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "CROM Baseline-2" immediately post-intervention

  5. Cervical Range of Motion (CROM) Change-3

    The evaluator will place the CROM-device® goniometer on the patient's head. It will ask you for movements of flexion, extension, right and left side flexion, and right and left rotation of the cervical spine. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "CROM Baseline-2" and "CROM Change-2" at 1 month

  6. Perceived Stress Scale (PSS-14) Baseline

    Perceived Stress Scale evaluates the level of perceived stress during the last month and consists of 14 items. The maximum score is 56 points. A higher score corresponds to a higher level of perceived stress.

    Time frame: Baseline

  7. PSS-14 Change

    Perceived Stress Scale evaluates the level of perceived stress during the last month and consists of 14 items. The maximum score is 56 points. A higher score corresponds to a higher level of perceived stress.

    Time frame: Change from Baseline PSS-14 at 1 month

  8. Mandibular Mobility Baseline-1

    For the measurement of vertical opening and lateral deviation of the mandible, the TheraBite® range of motion™ will be used. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Baseline pre-intervention

  9. Mandibular Mobility Change-1

    For the measurement of vertical opening and lateral deviation of the mandible, the TheraBite® range of motion™ will be used. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "Mandibular Mobility Baseline-1" immediately post-intervention

  10. Mandibular Mobility Baseline-2

    For the measurement of vertical opening and lateral deviation of the mandible, the TheraBite® range of motion™ will be used. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Baseline pre-intervention at 7 days

  11. Mandibular Mobility Change-2

    For the measurement of vertical opening and lateral deviation of the mandible, the TheraBite® range of motion™ will be used. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "Mandibular Mobility Baseline-2" immediately post-intervention

  12. Mandibular Mobility Change-3

    For the measurement of vertical opening and lateral deviation of the mandible, the TheraBite® range of motion™ will be used. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Time frame: Change from "Mandibular Mobility Baseline-2" and "Mandibular Mobility Change-2" at 1 month

  13. Pittsburgh Sleep Quality Index (PSQI) Baseline

    It is a tool used to assess the quality of sleep in the last month.It consists of 7 items that are rated on a scale of 0 to 3. An overall Pittsburgh Sleep Quality Index score greater than 5 produced diagnostic sensitivity and specificity in distinguishing good and poor sleepers.

    Time frame: Baseline

  14. PSQI Change

    It is a tool used to assess the quality of sleep in the last month.It consists of 7 items that are rated on a scale of 0 to 3. An overall Pittsburgh Sleep Quality Index score greater than 5 produced diagnostic sensitivity and specificity in distinguishing good and poor sleepers.

    Time frame: Change from Baseline PSQI at 1 month

07

Study locations

1 of 1 sites recruiting
  • Nursing, Physiotherapy and Podiatry Faculty
    Seville, 41009, Spain
    Recruiting
    • Lourdes María Fernández-Seguín, PhD · Contact
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05751694
Responsible party
Lourdes María Fernández Seguín (Assistant Professor. Physiotherapy Department, University of Seville) — Principal investigator
First posted
Mar 2, 2023
Start date
Mar 1, 2023
Primary completion
Mar 1, 2025 (estimated)
Completion
Mar 1, 2026 (estimated)
Last update
Feb 26, 2025

Study contacts

Lourdes M Fernández Seguín, PhD
Contact
lfdez@us.es
630258773 ext. +34
Cayetano Navarro Rico, Phd Student
Contact
cayetanonavarro95@gmail.com
664894442 ext. +34
Lourdes M Fernández Seguín, PhD
principal investigator · University of Seville

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion